Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

JENNI KATE MILES

Allopathic & Osteopathic Physicians Family Medicine

NPI
1790417251
CMS profile
11558287
Location
KOSCIUSKO, MS

General Payments · PY2023–2025

$376.75

  • Reported across 22 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$277.39

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $277.39 16

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $80.82 5
Acerta Pharma LLC $64.20 4
Otsuka America Pharmaceutical, Inc. $53.29 2
PFIZER INC. $30.03 2
Bayer HealthCare Pharmaceuticals Inc. $19.54 1
GlaxoSmithKline, LLC. $15.96 1
ABBVIE INC. $13.55 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $27.87 2
PY2024 $71.49 4
PY2025 $277.39 16

Payment records · PY2025 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2025 20232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $13.55 03/28/2025 Food and Beverage Undisputed 06/30/2026 1203083319 CMS
AstraZeneca Pharmaceuticals LP $16.05 08/12/2025 Food and Beverage Undisputed 06/30/2026 1206462317 CMS
AstraZeneca Pharmaceuticals LP $16.05 09/09/2025 Food and Beverage Undisputed 06/30/2026 1206463089 CMS
AstraZeneca Pharmaceuticals LP $16.05 10/08/2025 Food and Beverage Undisputed 06/30/2026 1206659697 CMS
AstraZeneca Pharmaceuticals LP $16.05 11/04/2025 Food and Beverage Undisputed 06/30/2026 1206641113 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.54 03/24/2025 Food and Beverage Undisputed 06/30/2026 1225654218 CMS
GlaxoSmithKline, LLC. $15.96 10/25/2025 Food and Beverage Undisputed 06/30/2026 1190702540 CMS
Novo Nordisk Inc $13.69 08/21/2025 Food and Beverage Undisputed 06/30/2026 1188876243 CMS
Novo Nordisk Inc $17.73 09/18/2025 Food and Beverage Undisputed 06/30/2026 1188188799 CMS
Novo Nordisk Inc $18.46 10/09/2025 Food and Beverage Undisputed 06/30/2026 1188562954 CMS
Novo Nordisk Inc $16.31 11/20/2025 Food and Beverage Undisputed 06/30/2026 1188194559 CMS
Novo Nordisk Inc $14.63 12/02/2025 Food and Beverage Undisputed 06/30/2026 1188852351 CMS
Otsuka America Pharmaceutical, Inc. $23.29 05/21/2025 Food and Beverage Undisputed 06/30/2026 1227417163 CMS
Otsuka America Pharmaceutical, Inc. $30.00 11/13/2025 Food and Beverage Undisputed 06/30/2026 1227417166 CMS
PFIZER INC. $15.34 11/11/2025 Food and Beverage Undisputed 06/30/2026 1230954511 CMS
PFIZER INC. $14.69 12/22/2025 Food and Beverage Undisputed 06/30/2026 1231117627 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.